Abstract
DILIsym Services, Inc. (DSSI) is a Simulations Plus company. Simulations Plus develops modeling and simulation software for pharmaceutical and biotechnical industries .Software designed to support drug discovery, clinical development research, and regulatory submissions DSSI uses quantitative systems pharmacology (QSP) and quantitative systems toxicology (QST) to support the pharmaceutical industry. DSSI has developed numerous modeling software platforms to support the development of safe and effective drug therapies. Focused on improving drug safety through QST models and supporting development of efficacious treatments through QSP models. Learn more here: https://www.simulations-plus.com/dilisym-services/
By Christina Battista